Rudnicki Anya, Shivatzki Shaked, Beyer Lisa A, Takada Yohei, Raphael Yehoash, Avraham Karen B
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 68878, Israel and.
Kresge Hearing Research Institute, Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
Hum Mol Genet. 2014 Jun 15;23(12):3138-46. doi: 10.1093/hmg/ddu023. Epub 2014 Jan 26.
microRNAs (miRNAs) are regulators of differentiation and development of inner ear cells. Mutations in miRNAs lead to deafness in humans and mice. Among inner ear pathologies, inflammation may lead to structural and neuronal defects and eventually to hearing loss and vestibular dysfunction. While the genetic factors of these pathways have not been defined, autoimmunity participates in these processes. We report that inflammatory stimuli in the inner ear induce activation of the innate immune system via miR-224 and pentraxin 3 (Ptx3). miR-224 is a transcriptional target of nuclear factor κB, a key mediator of innate immunity. Ptx3 is a regulator of the immune response. It is released in response to inflammation and regulated by nuclear factor κB. We show that miR-224 and Ptx3 are expressed in the inner ear and we demonstrate that miR-224 targets Ptx3. As a model of the innate immune response, we injected lipopolysaccharide into the scala tympani of mouse inner ears. This resulted in changes in the levels of miR-224 and Ptx3, in addition to activation of the complement system, as measured by immune cell infiltration and activated C3. This suggests that while miR-224 regulates Ptx3 under normal conditions, upon inflammation, both are recruited to offer a front line of defense in acting as responders to inflammation in the inner ear. miR-224 diminishes the innate immune response by down-regulating Ptx3 expression, while Ptx3 stimulates the innate immune response. An understanding of the molecular components of the inflammatory pathway may help develop therapeutics for reducing inflammation associated with inner ear injury.
微小RNA(miRNA)是内耳细胞分化和发育的调节因子。miRNA的突变会导致人类和小鼠耳聋。在内耳病变中,炎症可能导致结构和神经元缺陷,并最终导致听力丧失和前庭功能障碍。虽然这些途径的遗传因素尚未明确,但自身免疫参与了这些过程。我们报告称,内耳中的炎症刺激通过miR-224和五聚素3(Ptx3)诱导先天免疫系统的激活。miR-224是先天免疫的关键介质核因子κB的转录靶点。Ptx3是免疫反应的调节因子。它在炎症反应中释放,并受核因子κB调控。我们发现miR-224和Ptx3在内耳中表达,并证明miR-224靶向Ptx3。作为先天免疫反应的模型,我们将脂多糖注射到小鼠内耳的鼓阶中。这除了激活补体系统外,还导致了miR-224和Ptx3水平的变化,补体系统的激活通过免疫细胞浸润和活化的C3来衡量。这表明,虽然在正常条件下miR-224调节Ptx3,但在炎症发生时,二者都被招募来在内耳炎症反应中充当一线防御者。miR-224通过下调Ptx3表达来减弱先天免疫反应,而Ptx3则刺激先天免疫反应。了解炎症途径的分子成分可能有助于开发减轻内耳损伤相关炎症的治疗方法。